On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes
- PMID: 34296322
- DOI: 10.1007/s00125-021-05505-4
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes
Abstract
Hundreds of millions of people are affected by hyperinsulinaemia, insulin resistance, obesity and the dysglycaemia that mark a common progression from metabolic health to type 2 diabetes. Although the relative contribution of these features and the order in which they appear may differ between individuals, the common clustering and seemingly progressive nature of type 2 diabetes aetiology has guided research and clinical practice in this area for decades. At the same time, lively debate around the causal relationships between these features has continued, as new data from human trials and highly controlled animal studies are presented. This 'For debate' article was prompted by the review in Diabetologia by Esser, Utzschneider and Kahn ( https://doi.org/10.1007/s00125-020-05245-x ), with the purpose of reviewing established and emerging data that provide insight into the relative contributions of hyperinsulinaemia and impaired glucose-stimulated insulin secretion in progressive stages between health, obesity and diabetes. It is concluded that these beta cell defects are not mutually exclusive and that they are both important, but at different stages.
Keywords: Dysglycaemia; Human studies; Hyperinsulinaemia; Insulin resistance; Insulin secretion; Mouse models; Obesity; Pancreatic islet beta cells; Review; Type 2 diabetes.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Comment in
-
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes: Reply to Johnson JD [letter].Diabetologia. 2021 Oct;64(10):2345-2347. doi: 10.1007/s00125-021-05511-6. Epub 2021 Jul 29. Diabetologia. 2021. PMID: 34324020 No abstract available.
Comment on
-
Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia.Diabetologia. 2020 Oct;63(10):2007-2021. doi: 10.1007/s00125-020-05245-x. Epub 2020 Sep 7. Diabetologia. 2020. PMID: 32894311 Review.
References
-
- Esser N, Utzschneider KM, Kahn SE (2020) Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia 63(10):2007–2021. https://doi.org/10.1007/s00125-020-05245-x - DOI - PubMed
-
- Wagner R, Heni M, Tabak AG et al (2021) Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes. Nat Med 27:49–75. https://doi.org/10.1038/s41591-020-1116-9 - DOI - PubMed
-
- Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J (2008) Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31(Suppl 2):S262–S268. https://doi.org/10.2337/dc08-s264 - DOI - PubMed
-
- Corkey BE (2012) Banting lecture 2011: hyperinsulinemia: cause or consequence? Diabetes 61(1):4–13. https://doi.org/10.2337/db11-1483 - DOI - PubMed
-
- Erion K, Corkey BE (2018) Beta-cell failure or beta-cell abuse? Front Endocrinol (Lausanne) 9:532. https://doi.org/10.3389/fendo.2018.00532 - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
